These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation]. Zhong S; Zhang H; Bai D; Gao D; Zheng J; Ding Y Zhonghua Bing Li Xue Za Zhi; 2015 Sep; 44(9):639-43. PubMed ID: 26705279 [TBL] [Abstract][Full Text] [Related]
5. Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer. Lindquist KE; Karlsson A; Levéen P; Brunnström H; Reuterswärd C; Holm K; Jönsson M; Annersten K; Rosengren F; Jirström K; Kosieradzki J; Ek L; Borg Å; Planck M; Jönsson G; Staaf J Oncotarget; 2017 May; 8(21):34796-34810. PubMed ID: 28415793 [TBL] [Abstract][Full Text] [Related]
6. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. Inamura K; Takeuchi K; Togashi Y; Nomura K; Ninomiya H; Okui M; Satoh Y; Okumura S; Nakagawa K; Soda M; Choi YL; Niki T; Mano H; Ishikawa Y J Thorac Oncol; 2008 Jan; 3(1):13-7. PubMed ID: 18166835 [TBL] [Abstract][Full Text] [Related]
7. KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung. Yokota K; Sasaki H; Okuda K; Shimizu S; Shitara M; Hikosaka Y; Moriyama S; Yano M; Fujii Y Oncol Rep; 2012 Oct; 28(4):1187-92. PubMed ID: 22797671 [TBL] [Abstract][Full Text] [Related]
8. A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer. Wijesinghe P; Bepler G; Bollig-Fischer A J Thorac Oncol; 2015 Feb; 10(2):381-6. PubMed ID: 25384172 [TBL] [Abstract][Full Text] [Related]
9. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare. Zhao W; Choi YL; Song JY; Zhu Y; Xu Q; Zhang F; Jiang L; Cheng J; Zheng G; Mao M Lung Cancer; 2016 Apr; 94():22-7. PubMed ID: 26973202 [TBL] [Abstract][Full Text] [Related]
10. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations. Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493 [TBL] [Abstract][Full Text] [Related]
11. Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma. Strohmeier S; Brcic I; Popper H; Liegl-Atzwanger B; Lindenmann J; Brcic L Sci Rep; 2021 May; 11(1):9785. PubMed ID: 33963267 [TBL] [Abstract][Full Text] [Related]
12. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases]. Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587 [No Abstract] [Full Text] [Related]
13. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression. Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations]. Fang F; Qiao XB; Yang L; Di J; Hu ST; Liu DG; Lyu N Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):270-275. PubMed ID: 30955261 [No Abstract] [Full Text] [Related]
15. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350 [TBL] [Abstract][Full Text] [Related]
16. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance. Vollbrecht C; Lenze D; Hummel M; Lehmann A; Moebs M; Frost N; Jurmeister P; Schweizer L; Kellner U; Dietel M; von Laffert M BMC Cancer; 2018 Nov; 18(1):1158. PubMed ID: 30466405 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung. Sakai Y; Nakai T; Ohbayashi C; Imagawa N; Yanagita E; Satake R; Nitta A; Kajimoto K; Sakuma T; Itoh T Int J Surg Pathol; 2013 Oct; 21(5):476-82. PubMed ID: 23794492 [TBL] [Abstract][Full Text] [Related]
18. TaqMan based real time PCR assay targeting EML4-ALK fusion transcripts in NSCLC. Robesova B; Bajerova M; Liskova K; Skrickova J; Tomiskova M; Pospisilova S; Mayer J; Dvorakova D Lung Cancer; 2014 Jul; 85(1):25-30. PubMed ID: 24792336 [TBL] [Abstract][Full Text] [Related]
19. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. Lira ME; Choi YL; Lim SM; Deng S; Huang D; Ozeck M; Han J; Jeong JY; Shim HS; Cho BC; Kim J; Ahn MJ; Mao M J Mol Diagn; 2014 Mar; 16(2):229-43. PubMed ID: 24418728 [TBL] [Abstract][Full Text] [Related]
20. A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas. Li X; Shi G; Chu Q; Jiang W; Liu Y; Zhang S; Zhang Z; Wei Z; He F; Guo Z; Qi L BMC Genomics; 2019 Nov; 20(1):881. PubMed ID: 31752667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]